title: Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue.
authors.affiliation: School of Social and Community Medicine, University of Bristol, Bristol, UK. matthew.hickman@bristol.ac.uk.
authors.forename: M
authors.initials: M
authors.lastname: Hickman
authors.forename: N
authors.initials: N
authors.lastname: Martin
authors.forename: P
authors.initials: P
authors.lastname: Vickerman
authors.forename: S
authors.initials: S
authors.lastname: Hutchinson
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D008297:Male
chemical_list: D000998:Antiviral Agents